Medicus Pharma Ltd (MDCX)

09:22 AM

Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan - TipRanks

09:22 AM

08:36 AM

Medicus Pharma advances SkinJect, Teverelix programs, eyes catalyst-rich 2026 - Proactive financial news

08:36 AM

08:09 AM

Medicus Pharma reports 80% response rate in skin cancer study By Investing.com - Investing.com India

08:09 AM

07:30 AM

Three in four lesions cleared in Medicus skin cancer study at Day 57 - Stock Titan

07:30 AM

01:58 AM

Medicus Biosciences—Biotech Company Focused on Innovative Microneedle Technology and Global Patent Portfolio - Minichart

01:58 AM

Mar 25, 2026

Medicus Pharma Advances SkinJect and Teverelix Pipelines, Adds AI to Clinical Strategy - TipRanks

Mar 25, 2026

Mar 25, 2026

Medicus Pharma Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 25, 2026

Mar 25, 2026

Medicus Pharma (MDCX) registers 7.5M shares; Phase 2 D‑MNA topline noted - Stock Titan

Mar 25, 2026

Mar 25, 2026

Medicus Pharma (NASDAQ: MDCX) registers 3.245M common shares from warrants - Stock Titan

Mar 25, 2026

Mar 25, 2026

Medicus Pharma (MDCX) 1.12M shares issuable on warrants — prospectus supplement - Stock Titan

Mar 25, 2026

Mar 25, 2026

Medicus Pharma (MDCX) registers 2.26M shares tied to public warrants - Stock Titan

Mar 25, 2026

Mar 25, 2026

1.397M resale shares registered as Medicus Pharma (NASDAQ: MDCX) shifts S-1 to S-3 - Stock Titan

Mar 25, 2026

Mar 25, 2026

[POS AM] Medicus Pharma Ltd. S... - Stock Titan

Mar 25, 2026

Mar 25, 2026

Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update - ACCESS Newswire

Mar 25, 2026

Mar 25, 2026

Biotech says 3 in 4 patients may avoid immediate skin cancer surgery - Stock Titan

Mar 25, 2026

Mar 25, 2026

Medicus Pharma 2025 10-K: Net loss $35.4M, EPS $(2.74) - TradingView

Mar 25, 2026

Mar 24, 2026

Medicus Pharma to host business update call featuring clinical investigator - MSN

Mar 24, 2026

Mar 24, 2026

Medicus Pharma on Bloomberg World - Daytona Beach News-Journal

Mar 24, 2026

Mar 24, 2026

Medicus Pharma to Host Business Update Call Featuring Clinical Investigator - MyChesCo

Mar 24, 2026

Mar 23, 2026

Medicus Pharma reports phase 2 results for basal cell carcinoma therapy - MSN

Mar 23, 2026

Mar 23, 2026

Medicus Pharma stock swings after skin cancer treatment results - MSN

Mar 23, 2026

Mar 22, 2026

Tangible book value per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Mar 22, 2026

Mar 22, 2026

Book value per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Mar 22, 2026

Mar 21, 2026

Whats next for Medicus Pharma Ltd Equity Warrant stock2026 Technical Overview & Precise Swing Trade Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 21, 2026

Medicus reports phase 2 results for SkinJect basal cell carcinoma study - MSN

Mar 21, 2026

Mar 20, 2026

Medicus Pharma Ltd expected to post a loss of 15 cents a shareEarnings Preview - TradingView

Mar 20, 2026

Mar 19, 2026

Analyst Calls: Is Medicus Pharma Ltd exposed to currency risks2026 Price Swings & Technical Entry and Exit Tips - baoquankhu1.vn

Mar 19, 2026

Mar 19, 2026

Medicus Pharma to host fireside chat on SkinJect trial results By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 18, 2026

MDCXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 18, 2026

Mar 18, 2026

Will Medicus Pharma Ltd outperform the market in YEARDividend Hike & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

Medicus Pharma prices $7 million share offering - MSN

Mar 18, 2026

Mar 18, 2026

Medicus Pharma Showcases Strong Phase 2 SkinJect Data Ahead of Fireside Chat - TipRanks

Mar 18, 2026

Mar 18, 2026

Medicus Pharma to host fireside chat on SkinJect trial results - Investing.com

Mar 18, 2026

Mar 18, 2026

Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst - ACCESS Newswire

Mar 18, 2026

Mar 18, 2026

Medicus Pharma (MDCX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat

Mar 18, 2026

Mar 17, 2026

Aug Sectors: What is the dividend yield of Medicus Pharma Ltd Equity Warrant2026 Sector Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Medicus Pharma schedules webcast on basal cell carcinoma study By Investing.com - Investing.com Australia

Mar 17, 2026

Mar 16, 2026

Aug Opening: Is Medicus Pharma Ltd Equity Warrant a speculative investment2026 Volume & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Investment Recap: Can Medicus Pharma Ltd sustain its profitabilityTrade Exit Report & Technical Entry and Exit Tips - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Medicus Pharma to highlight positive Phase 2 SkinJect data during webcast with lead investigator - Proactive financial news

Mar 16, 2026

Mar 16, 2026

Medicus Pharma Highlights Strong Phase 2 SkinJect Data Ahead of Business Update Call - TipRanks

Mar 16, 2026

Mar 16, 2026

Medicus Pharma schedules webcast on basal cell carcinoma study - Investing.com

Mar 16, 2026

Mar 16, 2026

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26 - ChartMill

Mar 16, 2026

Mar 15, 2026

Medicus Reports Phase 2 Results for SkinJect Basal Cell Carcinoma Study - MyChesCo

Mar 15, 2026

Mar 14, 2026

Medicus Pharma CEO discusses promising Phase 2 SkinJect resultsICYMI - Proactive financial news

Mar 14, 2026

Mar 13, 2026

Medicus Pharma Marks Nasdaq Anniversary with Opening Bell Ceremony - The Globe and Mail

Mar 13, 2026